ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global VHH Nanobodies Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-38Z17824
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global VHH Nanobodies Market Research Report 2024
BUY CHAPTERS

Global VHH Nanobodies Market Research Report 2024

Code: QYRE-Auto-38Z17824
Report
August 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sino Biological
GenScript
Proteintech Group
Abiocenter
PREGENE
Cusabio
BIOCYTOGEN
Thermo Fisher Scientific
HuaBio
Jackson ImmunoResearch
MerryBio
QVQuality

VHH Nanobodies Market

In the peripheral blood of camel species such as alpacas, there is an antibody that naturally lacks light chains. It is a natural dimer formed by two heavy chains, called a heavy chain antibody. The variable region of this heavy chain antibody is called VHH, which can bind to antigens as a single molecule and has high affinity and high specificity. VHH crystals are 2.5nm, 4nm long, and have a molecular weight of only 15 kDa, so they are also called nano antibodies. VHH is not as easy to adhere to each other as artificially modified single-chain antibody fragments (scFV), but is more stable and can even be stored at room temperature. The half-life of nano antibodies can be extended and antibody drugs can be produced by constructing bifunctional domain or trifunctional domain antibodies that recognize HSA, or constructing Fc fusion proteins.
The global VHH Nanobodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for VHH Nanobodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for VHH Nanobodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of VHH Nanobodies include Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for VHH Nanobodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding VHH Nanobodies.
The VHH Nanobodies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global VHH Nanobodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the VHH Nanobodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of VHH Nanobodies Market Report

Report Metric Details
Report Name VHH Nanobodies Market
Segment by Type
Segment by Application
  • Treatment
  • Diagnosis
  • Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, HUABIO, Jackson ImmunoResearch
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of VHH Nanobodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of VHH Nanobodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the VHH Nanobodies Market report?

Ans: The main players in the VHH Nanobodies Market are Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, HUABIO, Jackson ImmunoResearch

What are the Application segmentation covered in the VHH Nanobodies Market report?

Ans: The Applications covered in the VHH Nanobodies Market report are Treatment, Diagnosis, Research

What are the Type segmentation covered in the VHH Nanobodies Market report?

Ans: The Types covered in the VHH Nanobodies Market report are Monovalent Nanobodies, Bivalent Nanobodies, Bispecific Nanobodies, Multivalent Nanobodies, Fused Nanobodies

Recommended Reports

Antibody Therapeutics

Nanobody & Nanomedicine

Diagnosis & Treatment

1 VHH Nanobodies Market Overview
1.1 Product Definition
1.2 VHH Nanobodies by Type
1.2.1 Global VHH Nanobodies Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Nanobodies
1.2.3 Bivalent Nanobodies
1.2.4 Bispecific Nanobodies
1.2.5 Multivalent Nanobodies
1.2.6 Fused Nanobodies
1.3 VHH Nanobodies by Application
1.3.1 Global VHH Nanobodies Market Value by Application (2024-2030)
1.3.2 Treatment
1.3.3 Diagnosis
1.3.4 Research
1.4 Global VHH Nanobodies Market Size Estimates and Forecasts
1.4.1 Global VHH Nanobodies Revenue 2019-2030
1.4.2 Global VHH Nanobodies Sales 2019-2030
1.4.3 Global VHH Nanobodies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 VHH Nanobodies Market Competition by Manufacturers
2.1 Global VHH Nanobodies Sales Market Share by Manufacturers (2019-2024)
2.2 Global VHH Nanobodies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global VHH Nanobodies Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of VHH Nanobodies, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of VHH Nanobodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of VHH Nanobodies, Product Type & Application
2.7 Global Key Manufacturers of VHH Nanobodies, Date of Enter into This Industry
2.8 Global VHH Nanobodies Market Competitive Situation and Trends
2.8.1 Global VHH Nanobodies Market Concentration Rate
2.8.2 The Global 5 and 10 Largest VHH Nanobodies Players Market Share by Revenue
2.8.3 Global VHH Nanobodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global VHH Nanobodies Market Scenario by Region
3.1 Global VHH Nanobodies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global VHH Nanobodies Sales by Region: 2019-2030
3.2.1 Global VHH Nanobodies Sales by Region: 2019-2024
3.2.2 Global VHH Nanobodies Sales by Region: 2025-2030
3.3 Global VHH Nanobodies Revenue by Region: 2019-2030
3.3.1 Global VHH Nanobodies Revenue by Region: 2019-2024
3.3.2 Global VHH Nanobodies Revenue by Region: 2025-2030
3.4 North America VHH Nanobodies Market Facts & Figures by Country
3.4.1 North America VHH Nanobodies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America VHH Nanobodies Sales by Country (2019-2030)
3.4.3 North America VHH Nanobodies Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe VHH Nanobodies Market Facts & Figures by Country
3.5.1 Europe VHH Nanobodies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe VHH Nanobodies Sales by Country (2019-2030)
3.5.3 Europe VHH Nanobodies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific VHH Nanobodies Market Facts & Figures by Region
3.6.1 Asia Pacific VHH Nanobodies Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific VHH Nanobodies Sales by Region (2019-2030)
3.6.3 Asia Pacific VHH Nanobodies Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America VHH Nanobodies Market Facts & Figures by Country
3.7.1 Latin America VHH Nanobodies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America VHH Nanobodies Sales by Country (2019-2030)
3.7.3 Latin America VHH Nanobodies Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa VHH Nanobodies Market Facts & Figures by Country
3.8.1 Middle East and Africa VHH Nanobodies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa VHH Nanobodies Sales by Country (2019-2030)
3.8.3 Middle East and Africa VHH Nanobodies Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global VHH Nanobodies Sales by Type (2019-2030)
4.1.1 Global VHH Nanobodies Sales by Type (2019-2024)
4.1.2 Global VHH Nanobodies Sales by Type (2025-2030)
4.1.3 Global VHH Nanobodies Sales Market Share by Type (2019-2030)
4.2 Global VHH Nanobodies Revenue by Type (2019-2030)
4.2.1 Global VHH Nanobodies Revenue by Type (2019-2024)
4.2.2 Global VHH Nanobodies Revenue by Type (2025-2030)
4.2.3 Global VHH Nanobodies Revenue Market Share by Type (2019-2030)
4.3 Global VHH Nanobodies Price by Type (2019-2030)
5 Segment by Application
5.1 Global VHH Nanobodies Sales by Application (2019-2030)
5.1.1 Global VHH Nanobodies Sales by Application (2019-2024)
5.1.2 Global VHH Nanobodies Sales by Application (2025-2030)
5.1.3 Global VHH Nanobodies Sales Market Share by Application (2019-2030)
5.2 Global VHH Nanobodies Revenue by Application (2019-2030)
5.2.1 Global VHH Nanobodies Revenue by Application (2019-2024)
5.2.2 Global VHH Nanobodies Revenue by Application (2025-2030)
5.2.3 Global VHH Nanobodies Revenue Market Share by Application (2019-2030)
5.3 Global VHH Nanobodies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sino Biological
6.1.1 Sino Biological Company Information
6.1.2 Sino Biological Description and Business Overview
6.1.3 Sino Biological VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sino Biological VHH Nanobodies Product Portfolio
6.1.5 Sino Biological Recent Developments/Updates
6.2 GenScript
6.2.1 GenScript Company Information
6.2.2 GenScript Description and Business Overview
6.2.3 GenScript VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GenScript VHH Nanobodies Product Portfolio
6.2.5 GenScript Recent Developments/Updates
6.3 Proteintech Group
6.3.1 Proteintech Group Company Information
6.3.2 Proteintech Group Description and Business Overview
6.3.3 Proteintech Group VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Proteintech Group VHH Nanobodies Product Portfolio
6.3.5 Proteintech Group Recent Developments/Updates
6.4 Abiocenter
6.4.1 Abiocenter Company Information
6.4.2 Abiocenter Description and Business Overview
6.4.3 Abiocenter VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abiocenter VHH Nanobodies Product Portfolio
6.4.5 Abiocenter Recent Developments/Updates
6.5 MerryBio
6.5.1 MerryBio Company Information
6.5.2 MerryBio Description and Business Overview
6.5.3 MerryBio VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MerryBio VHH Nanobodies Product Portfolio
6.5.5 MerryBio Recent Developments/Updates
6.6 Pregene
6.6.1 Pregene Company Information
6.6.2 Pregene Description and Business Overview
6.6.3 Pregene VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pregene VHH Nanobodies Product Portfolio
6.6.5 Pregene Recent Developments/Updates
6.7 Cusabio
6.7.1 Cusabio Company Information
6.7.2 Cusabio Description and Business Overview
6.7.3 Cusabio VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Cusabio VHH Nanobodies Product Portfolio
6.7.5 Cusabio Recent Developments/Updates
6.8 Biocytogen
6.8.1 Biocytogen Company Information
6.8.2 Biocytogen Description and Business Overview
6.8.3 Biocytogen VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biocytogen VHH Nanobodies Product Portfolio
6.8.5 Biocytogen Recent Developments/Updates
6.9 Thermo Fisher Scientific
6.9.1 Thermo Fisher Scientific Company Information
6.9.2 Thermo Fisher Scientific Description and Business Overview
6.9.3 Thermo Fisher Scientific VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Thermo Fisher Scientific VHH Nanobodies Product Portfolio
6.9.5 Thermo Fisher Scientific Recent Developments/Updates
6.10 QVQuality
6.10.1 QVQuality Company Information
6.10.2 QVQuality Description and Business Overview
6.10.3 QVQuality VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.10.4 QVQuality VHH Nanobodies Product Portfolio
6.10.5 QVQuality Recent Developments/Updates
6.11 HUABIO
6.11.1 HUABIO Company Information
6.11.2 HUABIO Description and Business Overview
6.11.3 HUABIO VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.11.4 HUABIO VHH Nanobodies Product Portfolio
6.11.5 HUABIO Recent Developments/Updates
6.12 Jackson ImmunoResearch
6.12.1 Jackson ImmunoResearch Company Information
6.12.2 Jackson ImmunoResearch Description and Business Overview
6.12.3 Jackson ImmunoResearch VHH Nanobodies Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jackson ImmunoResearch VHH Nanobodies Product Portfolio
6.12.5 Jackson ImmunoResearch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 VHH Nanobodies Industry Chain Analysis
7.2 VHH Nanobodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 VHH Nanobodies Production Mode & Process
7.4 VHH Nanobodies Sales and Marketing
7.4.1 VHH Nanobodies Sales Channels
7.4.2 VHH Nanobodies Distributors
7.5 VHH Nanobodies Customers
8 VHH Nanobodies Market Dynamics
8.1 VHH Nanobodies Industry Trends
8.2 VHH Nanobodies Market Drivers
8.3 VHH Nanobodies Market Challenges
8.4 VHH Nanobodies Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sino Biological
GenScript
Proteintech Group
Abiocenter
PREGENE
Cusabio
BIOCYTOGEN
Thermo Fisher Scientific
HuaBio
Jackson ImmunoResearch
MerryBio
QVQuality
List of Tables
 Table 1. Global VHH Nanobodies Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global VHH Nanobodies Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global VHH Nanobodies Market Competitive Situation by Manufacturers in 2023
 Table 4. Global VHH Nanobodies Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global VHH Nanobodies Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global VHH Nanobodies Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global VHH Nanobodies Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market VHH Nanobodies Average Price (K US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of VHH Nanobodies, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of VHH Nanobodies, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of VHH Nanobodies, Product Type & Application
 Table 12. Global Key Manufacturers of VHH Nanobodies, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global VHH Nanobodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VHH Nanobodies as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global VHH Nanobodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global VHH Nanobodies Sales by Region (2019-2024) & (K Units)
 Table 18. Global VHH Nanobodies Sales Market Share by Region (2019-2024)
 Table 19. Global VHH Nanobodies Sales by Region (2025-2030) & (K Units)
 Table 20. Global VHH Nanobodies Sales Market Share by Region (2025-2030)
 Table 21. Global VHH Nanobodies Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global VHH Nanobodies Revenue Market Share by Region (2019-2024)
 Table 23. Global VHH Nanobodies Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global VHH Nanobodies Revenue Market Share by Region (2025-2030)
 Table 25. North America VHH Nanobodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America VHH Nanobodies Sales by Country (2019-2024) & (K Units)
 Table 27. North America VHH Nanobodies Sales by Country (2025-2030) & (K Units)
 Table 28. North America VHH Nanobodies Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America VHH Nanobodies Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe VHH Nanobodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe VHH Nanobodies Sales by Country (2019-2024) & (K Units)
 Table 32. Europe VHH Nanobodies Sales by Country (2025-2030) & (K Units)
 Table 33. Europe VHH Nanobodies Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe VHH Nanobodies Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific VHH Nanobodies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific VHH Nanobodies Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific VHH Nanobodies Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific VHH Nanobodies Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific VHH Nanobodies Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America VHH Nanobodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America VHH Nanobodies Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America VHH Nanobodies Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America VHH Nanobodies Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America VHH Nanobodies Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa VHH Nanobodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa VHH Nanobodies Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa VHH Nanobodies Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa VHH Nanobodies Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa VHH Nanobodies Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global VHH Nanobodies Sales (K Units) by Type (2019-2024)
 Table 51. Global VHH Nanobodies Sales (K Units) by Type (2025-2030)
 Table 52. Global VHH Nanobodies Sales Market Share by Type (2019-2024)
 Table 53. Global VHH Nanobodies Sales Market Share by Type (2025-2030)
 Table 54. Global VHH Nanobodies Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global VHH Nanobodies Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global VHH Nanobodies Revenue Market Share by Type (2019-2024)
 Table 57. Global VHH Nanobodies Revenue Market Share by Type (2025-2030)
 Table 58. Global VHH Nanobodies Price (K US$/Unit) by Type (2019-2024)
 Table 59. Global VHH Nanobodies Price (K US$/Unit) by Type (2025-2030)
 Table 60. Global VHH Nanobodies Sales (K Units) by Application (2019-2024)
 Table 61. Global VHH Nanobodies Sales (K Units) by Application (2025-2030)
 Table 62. Global VHH Nanobodies Sales Market Share by Application (2019-2024)
 Table 63. Global VHH Nanobodies Sales Market Share by Application (2025-2030)
 Table 64. Global VHH Nanobodies Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global VHH Nanobodies Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global VHH Nanobodies Revenue Market Share by Application (2019-2024)
 Table 67. Global VHH Nanobodies Revenue Market Share by Application (2025-2030)
 Table 68. Global VHH Nanobodies Price (K US$/Unit) by Application (2019-2024)
 Table 69. Global VHH Nanobodies Price (K US$/Unit) by Application (2025-2030)
 Table 70. Sino Biological Company Information
 Table 71. Sino Biological Description and Business Overview
 Table 72. Sino Biological VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sino Biological VHH Nanobodies Product
 Table 74. Sino Biological Recent Developments/Updates
 Table 75. GenScript Company Information
 Table 76. GenScript Description and Business Overview
 Table 77. GenScript VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 78. GenScript VHH Nanobodies Product
 Table 79. GenScript Recent Developments/Updates
 Table 80. Proteintech Group Company Information
 Table 81. Proteintech Group Description and Business Overview
 Table 82. Proteintech Group VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 83. Proteintech Group VHH Nanobodies Product
 Table 84. Proteintech Group Recent Developments/Updates
 Table 85. Abiocenter Company Information
 Table 86. Abiocenter Description and Business Overview
 Table 87. Abiocenter VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 88. Abiocenter VHH Nanobodies Product
 Table 89. Abiocenter Recent Developments/Updates
 Table 90. MerryBio Company Information
 Table 91. MerryBio Description and Business Overview
 Table 92. MerryBio VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 93. MerryBio VHH Nanobodies Product
 Table 94. MerryBio Recent Developments/Updates
 Table 95. Pregene Company Information
 Table 96. Pregene Description and Business Overview
 Table 97. Pregene VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 98. Pregene VHH Nanobodies Product
 Table 99. Pregene Recent Developments/Updates
 Table 100. Cusabio Company Information
 Table 101. Cusabio Description and Business Overview
 Table 102. Cusabio VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 103. Cusabio VHH Nanobodies Product
 Table 104. Cusabio Recent Developments/Updates
 Table 105. Biocytogen Company Information
 Table 106. Biocytogen Description and Business Overview
 Table 107. Biocytogen VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 108. Biocytogen VHH Nanobodies Product
 Table 109. Biocytogen Recent Developments/Updates
 Table 110. Thermo Fisher Scientific Company Information
 Table 111. Thermo Fisher Scientific Description and Business Overview
 Table 112. Thermo Fisher Scientific VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 113. Thermo Fisher Scientific VHH Nanobodies Product
 Table 114. Thermo Fisher Scientific Recent Developments/Updates
 Table 115. QVQuality Company Information
 Table 116. QVQuality Description and Business Overview
 Table 117. QVQuality VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 118. QVQuality VHH Nanobodies Product
 Table 119. QVQuality Recent Developments/Updates
 Table 120. HUABIO Company Information
 Table 121. HUABIO Description and Business Overview
 Table 122. HUABIO VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 123. HUABIO VHH Nanobodies Product
 Table 124. HUABIO Recent Developments/Updates
 Table 125. Jackson ImmunoResearch Company Information
 Table 126. Jackson ImmunoResearch Description and Business Overview
 Table 127. Jackson ImmunoResearch VHH Nanobodies Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
 Table 128. Jackson ImmunoResearch VHH Nanobodies Product
 Table 129. Jackson ImmunoResearch Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. VHH Nanobodies Distributors List
 Table 133. VHH Nanobodies Customers List
 Table 134. VHH Nanobodies Market Trends
 Table 135. VHH Nanobodies Market Drivers
 Table 136. VHH Nanobodies Market Challenges
 Table 137. VHH Nanobodies Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of VHH Nanobodies
 Figure 2. Global VHH Nanobodies Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global VHH Nanobodies Market Share by Type: 2023 & 2030
 Figure 4. Monovalent Nanobodies Product Picture
 Figure 5. Bivalent Nanobodies Product Picture
 Figure 6. Bispecific Nanobodies Product Picture
 Figure 7. Multivalent Nanobodies Product Picture
 Figure 8. Fused Nanobodies Product Picture
 Figure 9. Global VHH Nanobodies Market Value by Application (2024-2030) & (US$ Million)
 Figure 10. Global VHH Nanobodies Market Share by Application: 2023 & 2030
 Figure 11. Treatment
 Figure 12. Diagnosis
 Figure 13. Research
 Figure 14. Global VHH Nanobodies Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global VHH Nanobodies Market Size (2019-2030) & (US$ Million)
 Figure 16. Global VHH Nanobodies Sales (2019-2030) & (K Units)
 Figure 17. Global VHH Nanobodies Average Price (K US$/Unit) & (2019-2030)
 Figure 18. VHH Nanobodies Report Years Considered
 Figure 19. VHH Nanobodies Sales Share by Manufacturers in 2023
 Figure 20. Global VHH Nanobodies Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest VHH Nanobodies Players: Market Share by Revenue in VHH Nanobodies in 2023
 Figure 22. VHH Nanobodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global VHH Nanobodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America VHH Nanobodies Sales Market Share by Country (2019-2030)
 Figure 25. North America VHH Nanobodies Revenue Market Share by Country (2019-2030)
 Figure 26. United States VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe VHH Nanobodies Sales Market Share by Country (2019-2030)
 Figure 29. Europe VHH Nanobodies Revenue Market Share by Country (2019-2030)
 Figure 30. Germany VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific VHH Nanobodies Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific VHH Nanobodies Revenue Market Share by Region (2019-2030)
 Figure 37. China VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America VHH Nanobodies Sales Market Share by Country (2019-2030)
 Figure 45. Mexico VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa VHH Nanobodies Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa VHH Nanobodies Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE VHH Nanobodies Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of VHH Nanobodies by Type (2019-2030)
 Figure 55. Global Revenue Market Share of VHH Nanobodies by Type (2019-2030)
 Figure 56. Global VHH Nanobodies Price (K US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of VHH Nanobodies by Application (2019-2030)
 Figure 58. Global Revenue Market Share of VHH Nanobodies by Application (2019-2030)
 Figure 59. Global VHH Nanobodies Price (K US$/Unit) by Application (2019-2030)
 Figure 60. VHH Nanobodies Value Chain
 Figure 61. VHH Nanobodies Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global VHH Antibody Drugs Market Research Report 2024
Global Nanobody Sequence Library Market Research Report 2024
Global Construction of VHH antibody library Market Research Report 2024
Global Single Domain Antibody sdAbs Drugs Market Research Report 2024
Global Single Domain Heavy Chain Antibody Market Research Report 2025
Global Nanobody Discovery Service Market Research Report 2024
Global Single Domain Antibody Library Service Market Research Report 2024
Global Research Grade Antibodies Market Research Report 2024
Low Molecular Weight Heparin LMWHs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti HA Antibody Market Research Report 2024
Global Bi Specific Antibodies Therapy Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Recombinant Antibody scFv Production Services Market Research Report 2025
Global Custom Nanobody Service Market Research Report 2025
Global Anti Camelid VHH Antibody Market Research Report 2024
Global Keyhole Limpet Hemocyanin KLH Market Insights Forecast to 2030
Global Anti human Kappa Light Chains Market Research Report 2025
Global Bispecific Monoclonal Antibodies Market Research Report 2024
Bispecific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bi Specific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibody Therapeutic Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions